Doximity, Inc. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

430.77 k

Shareholding (Mar 2025)

FII

17.94%

Held by 197 FIIs

DII

24.21%

Held by 73 DIIs

Promoter

0.37%

How big is Doximity, Inc.?

22-Jun-2025

As of Jun 18, Doximity, Inc. has a market capitalization of $10.99 billion, with recent net sales of $570.40 million and a net profit of $223.19 million over the last four quarters.

What does Doximity, Inc. do?

22-Jun-2025

Doximity, Inc. is a mid-cap company in the Software Products industry, reporting net sales of $138 million and a net profit of $62 million as of March 2025, with a market cap of approximately $10.99 billion. Key metrics include a P/E ratio of 49.00 and a return on equity of 20.82%.

Is Doximity, Inc. technically bullish or bearish?

14-Oct-2025

As of October 10, 2025, Doximity, Inc. shows a mildly bullish trend with strong MACD and Bollinger Band signals, despite mixed indicators from Dow Theory, and has outperformed the S&P 500 year-to-date and over the past year.

Is Doximity, Inc. overvalued or undervalued?

28-Oct-2025

As of October 24, 2025, Doximity, Inc. is considered fairly valued despite a strong 61.18% return over the past year, with high valuation ratios (P/E of 49, Price to Book of 10.21, EV/EBITDA of 42.00) indicating potential overvaluation compared to peers.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

High Management Efficiency with a high ROE of 18.49%

Company has a low Debt to Equity ratio (avg) at times

Healthy long term growth as Net Sales has grown by an annual rate of 35.16% and Operating profit at 57.53%

The company has declared Positive results for the last 3 consecutive quarters

With ROE of 20.82%, it has a very attractive valuation with a 10.21 Price to Book Value

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Software Products

Market cap

USD 13,022 Million (Small Cap)

P/E

49.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.82

Return on Equity

23.14%

Price to Book

12.70

Revenue and Profits:

Net Sales:

146 Million

(Quarterly Results - Jun 2025)

Net Profit:

53 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-25.12%

6 Months

-5.97%

1 Year

-5.33%

2 Years

109.09%

3 Years

44.66%

4 Years

-14.28%

5 Years

0.0%

Doximity, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Doximity Stock Hits Day Low of $53.35 Amid Price Pressure

Doximity, Inc. faced a notable stock decline today, marking a challenging trading session. Despite recent short-term losses, the company has shown long-term resilience with a significant annual stock increase. Strong financial metrics, including high return on equity and robust cash flow, highlight its solid financial foundation and investor confidence.

Doximity, Inc. Experiences Revision in Its Stock Evaluation Amid Market Fluctuations

Doximity, Inc. has recently adjusted its valuation, with its stock price at $54.29, down from $62.58. Over the past year, it has achieved a 25.03% return, outperforming the S&P 500. Key metrics include a P/E ratio of 49 and a strong return on capital employed of 136.42%.

Is Doximity, Inc. overvalued or undervalued?

As of 24 October 2025, Doximity, Inc. has moved from an attractive to a fair valuation grade. The company appears to be overvalued based on its current metrics, with a P/E ratio of 49, a Price to Book Value of 10.21, and an EV to EBITDA of 42.00. In comparison to peers, Doximity's P/E ratio is significantly lower than Commvault Systems, Inc. at 91.74, but higher than BlackLine, Inc. at 35.70, indicating a mixed valuation landscape among competitors. Despite the recent stock price decline, Doximity has outperformed the S&P 500 over the year with a return of 61.18% compared to the index's 16.90%. This strong performance over the last year contrasts with its current overvaluation, suggesting that while the stock has delivered impressive returns, its high valuation ratios may not be sustainable moving forward....

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

35.16%

EBIT Growth (5y)

57.53%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.84

Sales to Capital Employed (avg)

0.52

Tax Ratio

15.32%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

261.78%

ROE (avg)

18.49%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

10.21

EV to EBIT

43.94

EV to EBITDA

42.00

EV to Capital Employed

59.94

EV to Sales

17.78

PEG Ratio

1.46

Dividend Yield

ROCE (Latest)

136.42%

ROE (Latest)

20.82%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

Bullish

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 107 Schemes (57.48%)

Foreign Institutions

Held by 197 Foreign Institutions (17.94%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 5.50% vs -17.97% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -14.72% vs -16.89% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "145.90",
          "val2": "138.30",
          "chgp": "5.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "57.50",
          "val2": "51.70",
          "chgp": "11.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.20",
          "val2": "-0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "53.30",
          "val2": "62.50",
          "chgp": "-14.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "374.80%",
          "val2": "353.20%",
          "chgp": "2.16%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 19.98% vs 13.43% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 51.22% vs 30.85% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "570.40",
          "val2": "475.40",
          "chgp": "19.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "241.40",
          "val2": "183.00",
          "chgp": "31.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.00",
          "val2": "-8.90",
          "chgp": "66.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "223.20",
          "val2": "147.60",
          "chgp": "51.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "404.60%",
          "val2": "363.40%",
          "chgp": "4.12%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

145.90

138.30

5.50%

Operating Profit (PBDIT) excl Other Income

57.50

51.70

11.22%

Interest

0.00

Exceptional Items

-0.20

Consolidate Net Profit

53.30

62.50

-14.72%

Operating Profit Margin (Excl OI)

374.80%

353.20%

2.16%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 5.50% vs -17.97% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -14.72% vs -16.89% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

570.40

475.40

19.98%

Operating Profit (PBDIT) excl Other Income

241.40

183.00

31.91%

Interest

0.00

Exceptional Items

-3.00

-8.90

66.29%

Consolidate Net Profit

223.20

147.60

51.22%

Operating Profit Margin (Excl OI)

404.60%

363.40%

4.12%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 19.98% vs 13.43% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 51.22% vs 30.85% in Mar 2024

All Annual Results

Company CV

About Doximity, Inc.

Doximity, Inc.

Software Products

No Details Available.

Company Coordinates

No Company Details Available

Doximity, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Doximity, Inc.?

Watch in Real-Time

What does Doximity, Inc. do?

Is Doximity, Inc. technically bullish or bearish?

Is Doximity, Inc. overvalued or undervalued?

MarketsMojo — Loved in India, Now Global

Dashboard

High Management Efficiency with a high ROE of 18.49%

Company has a low Debt to Equity ratio (avg) at times

Healthy long term growth as Net Sales has grown by an annual rate of 35.16% and Operating profit at 57.53%

The company has declared Positive results for the last 3 consecutive quarters

With ROE of 20.82%, it has a very attractive valuation with a 10.21 Price to Book Value

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Doximity Stock Hits Day Low of $53.35 Amid Price Pressure

Doximity, Inc. Experiences Revision in Its Stock Evaluation Amid Market Fluctuations

Is Doximity, Inc. overvalued or undervalued?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Annual Results Snapshot (Consolidated) - Mar'25

About Doximity, Inc.

Company Coordinates